Some reading on previous results of OV-101 in Angelman Syndrome
https://www.fiercebiotech.com/biotech/journey-a-rare-disease-drug-ovid-s-ov101-for-angelman-syndrome
https://drug-dev.com/ovid-therapeutics-announces-positive-preclinical-data/
https://angelmansyndromenews.com/ne...r-angelman-syndrome-focus-of-clinical-trials/
OVID FAIL, page-5
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.71 |
Change
-0.590(3.41%) |
Mkt cap ! $2.135B | |||
| Open | High | Low | Value | Volume |
| $17.50 | $17.55 | $16.57 | $10.01M | 594.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 598 | $16.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.87 | 1676 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |